Advertisement

Topics

Press Releases about Biotechnology, Pharmaceutical and Healthcare

16:43 EDT 28th September 2016 | BioPortfolio

Latest biotech, pharma, healthcare and medical device news.

Showing News Articles 1–25 of 100,000+

Wednesday 28th September 2016

Global Lyme Alliance Announces Formation of New 17-Member Young Leaders Council

The Council will provide a platform for young professionals in their 20s and 30s who are dedicated to volunteering their time, talents and energy to raise awareness of Lyme disease and further strengthen GLA's research mission. Greenwich, Connecticut (PRWEB) September 28, 2016 Global Lyme Alliance (GLA) is pleased to announce the formation of its new Young Leaders Council (YLC), a group compr...

Medtronic Receives FDA Approval for World's First Hybrid Closed Loop System for People with Type 1 Diabetes

The MiniMed® 670G System Features the Company's Most Advanced SmartGuard(TM) Algorithm To-Date DUBLIN - Sept. 28, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed® 670G system - the first Hybrid Closed Loop insulin delivery system approved anywhere i...

Onset Expands InTemp® Product Line for Pharmaceutical Cold Chain Monitoring with Two New Solutions

Bluetooth-enabled InTemp CX500 Series Loggers for in-transit monitoring and InTempConnect™ cloud-based data warehousing service provide end-to-end visibility throughout the supply chain BOSTON AND BOURNE, MA, (PRWEB) September 28, 2016 Onset, a world leader in data loggers, is expanding the company’s InTemp family of pharmaceutical cold chain management products with the launch of two new sol...

SalivaBio’s Saliva Collection Aid Receives PCT Patent Approval

SalivaBio, LLC, developers of innovative, easy to use saliva collection devices, and Johns Hopkins University announced today that they have received final approval from the United States Patent Office for their Saliva Collection Aid (SCA). The Saliva Collection Aid simplifies the collection of passive drool saliva biospecimens for salivary bioscience research, thereby reducing participant burden ...

Safety data for Lirilumab in combination with Nivolumab or Ipilimumab to be presented at the ESMO 2016 Congress

SAFETY DATA FOR LIRILUMAB IN COMBINATION WITH NIVOLUMAB OR IPILIMUMAB to be presented at the ESMO 2016 CONGRESS Marseille, September 28, 2016 Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that safety data for two Phase I studies of lirilumab in combination with nivolumab or ipilimumab conducted by Bristol-Myers Squibb in patie...

DuPont Pioneer & International Maize and Wheat Improvement Center Form CRISPR-Cas Public/Private Partnership

Agreement designed to improve livelihoods of smallholder maize and wheat farmers globally; Main focus: breeding for resistance to devastating maize lethal necrosis disease for Africa El Batán, Mexico (PRWEB) September 28, 2016 DuPont Pioneer and the International Maize and Wheat Improvement Center (CIMMYT) have entered into a Master Alliance Agreement to jointly develop improved crops using ...

ARKRAY USA, Inc., Introduces Assure SD Sharps Containers

MINNEAPOLIS, Sept. 28, 2016 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced today that the Company has launched a line of sharps containers for use in healthcare facilities. The Assure SD Sharps Container is designed with safety features to minimize needle sticks and combine cost-effective pricing to provide a value-filled option to healthcare facilities. Sharp...

WellCare to Release Third Quarter 2016 Results on November 1, 2016

TAMPA, Fla., Sept. 28, 2016 /PRNewswire/ -- WellCare Health Plans, Inc. (NYSE: WCG) today announced that it will release its financial results for the third quarter 2016 on Tuesday, November 1, 2016, at approximately 6:30 a.m. EDT. The company will also host a conference call at 8:30 a.m. EDT that morning to discuss its financial results. The conference call will be webcast live from the company'...

Landauer, Inc. Appoints Teri Fontenot to Board of Directors

GLENWOOD, Ill., Sept. 28, 2016 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring and outsourced medical physics services, today announced that Teri G. Fontenot has been appointed to the Board of Directors, effective September 28, 2016, expanding the Company's Board to nine directors. Ms. Fontenot has nearly 35 years...

Amgen Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In First Phase 3 Study

THOUSAND OAKS, Calif., Sept. 28, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced positive top-line results for erenumab (AMG 334) from A Phase 3, RandomIzed, double-blind, placebo-controlled Study to Evaluate the efficacy and safety of erenumab in migraine prevention (ARISE). These data showed the ARISE study met the primary endpoint, demonstrating a statistically significant reduction fr...

American Kratom Association: DEA Push To Schedule Natural Herb Kratom Will Harm Veterans, Seniors And Other Americans

WASHINGTON, Sept. 28, 2016 /PRNewswire-USNewswire/ -- The American Kratom Association (AKA) supports the legal use of kratom by millions of Americans. The Association believes that kratom should not be classified as a Schedule 1 drug by the Drug Enforcement Administration (DEA). In the words of AKA Founder Susan Ash: "Veterans, grandparents, and mature adults in all fields including medical and la...

Merrimack to Present Final Results of Phase 3 NAPOLI-1 Study at the European Society for Medical Oncology 2016 Congress

CAMBRIDGE, Mass., Sept. 28, 2016 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced it will present six posters from its systems-biology derived antibody engineering and nanotherapeutic portfolios at the European Society for Medical Oncology (ESMO) 2016 Congress, October 7 – 11, 2016 in Copenhagen, Denmark.   Merrimack will present the final result...

Securus Presents at Deutsche Bank Leveraged Finance Conference on September 27, 2016

DALLAS, Sept. 28, 2016 /PRNewswire/ -- Securus Technologies, a leading provider of civil and criminal justice technology solutions for public safety, investigation, corrections and monitoring, announced that it presented at the prestigious Deutsche Bank Leveraged Finance Conference on September 27, 2016. "We have presented at the Deutsche Bank Conference for the last seven (7) years, and we...

Geisinger Health System to acquire TCMC

SCRANTON, Pa., Sept. 28, 2016 /PRNewswire-USNewswire/ -- Officials from Geisinger Health System and The Commonwealth Medical College today announced they will join forces in their shared commitment to patients and the physicians who treat them.  Geisinger will acquire the Scranton-based medical college to form the new Geisinger Commonwealth College of Medicine, pending regulatory approva...

Bionor Pharma ASA - Mandatory notification of trade - Lars Høie

BIONOR PHARMA STOCK EXCHANGE ANNOUNCEMENT Lars Høie has on 28 September 2016 sold 25,000,000 shares, disposed of 1,500,000 Subscription Rights and exercised his remaining 96,199,303 Subscription Rights in the rights offering in Bionor Pharma ASA (the "Company"). Following these transactions and issuance of the new shares in the Rights Offering Lars Høie holds 121,453,370 shares, ...

The Maple Counseling Center Announces Honorees for 42nd Annual Maple Ball

Special Performance by Jane Lynch and Kate Flannery with the Tony Guerrero Trio Beverly Hills, California (PRWEB) September 28, 2016 The Maple Counseling Center, Los Angeles' leading organization dedicated to providing high quality, low cost counseling and mental health services to people of all ages and across all demographics, announced today that Dr. Drew Pinsky, Mason A. Sommers, PhD., an...

TV Star Shemar Moore and Mediaplanet Shed Light on Autoimmune Diseases

Mediaplanet today announces the launch of this fall’s edition of “Autoimmune Diseases.” New York, NY (PRWEB) September 28, 2016 This campaign will advocate for those living with autoimmune diseases like multiple sclerosis, rheumatoid arthritis, juvenile arthritis, Crohn’s disease, ulcerative colitis, among others, allowing readers to become part of the change needed to remedy this medical...

Nevada Heart And Vascular Center Announces Partnership With Desert Springs Hospital Offering First-Of-Its-Kind Naturally Dissolving Heart Stent For Patients With Coronary Artery Disease

LAS VEGAS, Sept. 28, 2016 /PRNewswire/ -- On Tuesday, September 27, Nevada Heart and Vascular Centers' Board Certified Interventional Cardiologist Rafael Valencia M.D., F.A.C.C., implanted a patient with the world's first FDA-approved dissolving heart stent. The Absorb bioresorbable vascular scaffold is a major advance in the treatment of coronary artery disease, which affects 15 million people in...

Louisburg College Goes the Extra Mile to Protect their Athletes by Testing with Wimbledon Health Partners

Louisburg College is well aware of the potential danger of sudden cardiac arrest, so partnering with Wimbledon Athletics to test their athletes for undiagnosed cardiovascular conditions only made sense Boca Raton, FL (PRWEB) September 28, 2016 Wimbledon Health Partners, the industry leader in on-site diagnostic testing for athletic programs and physicians, completed inaugural cardiovascular testi...

TALK ABOUT CURING AUTISM (TACA) Hosts 10TH Annual “Ante Up for Autism” Casino and Gala Event

Guests, sponsors, celebrities, and poker professionals will come together on Saturday, November 12, 2016 at 6:00pm at the Monarch Beach Resort in Dana Point, CA for a casino-themed fundraiser hosted by TACA. Join for dinner, silent auctions, and friendly poker games - all while raising money to provide Real Help Now for families affected by this prevalent and underfunded disease. Irvine, CA (PRWEB...

LBDA's New White Paper Explores the State of the Science and the Unprecedented Opportunity to Advance the Understanding and Treating Lewy Body Dementia

ATLANTA, Sept. 28, 2016 /PRNewswire-USNewswire/ -- The Lewy Body Dementia Association (LBDA) announced a new white paper that explores the state of the science for the most misdiagnosed form of dementia. The white paper was developed to create an awareness that there are increasing research opportunities to gain critical insights into LBD. Lewy body dementia is now recognized to be among the top t...

Additional Interim Data Supporting Long-Term Use of Vedolizumab in Patients with Ulcerative Colitis and Crohn's Disease Published in Journal of Crohn's and Colitis

OSAKA, Japan, Sept. 28, 2016 /PRNewswire/ -- Takeda Pharmaceutical Company Limited [TSE: 4502], ("Takeda") announced that two interim reports from the ongoing, open-label GEMINI long-term safety (LTS) study describing clinical data of long-term Entyvio (vedolizumab) treatment in patients with moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn's ...

Medtronic Receives FDA Clearance of TrailBlazer Angled Peripheral Support Catheter

TrailBlazer Angled Support Catheter Broadens Medtronic's Leading Peripheral Options Adding Full Spectrum of Angled Resources to Meet Provider Needs DUBLIN - September 28, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer(TM) angled support catheter for use in the peripheral vascular system. Support catheter...

Maruho and Astellas Enter License Agreement for the Development and Commercialization of a Topical Formulation of JAK Inhibitor peficitinib (ASP015K) for Treatment in the Skin Disease Area

Osaka and Tokyo (Japan), September 28, 2016 – Maruho Co., Ltd (“Maruho”, Head Office: Osaka, Japan, President and CEO: Koichi Takagi) and Astellas Pharma Inc. (“Astellas”; Head Office: Tokyo, President and CEO: Yoshihiko Hatanaka) announce today that they have entered into an exclusive license agreement for a novel, Janus Kinase (JAK) inhibitor developed by Astellas...

Cummings Institute Announces Partnership with STAX3D to Test How Virtual Reality Can Impact Mental Health

The Cummings Institute is to test the use of virtual reality in the treatment of patients with mental illness. The overall aim is to use this technology to revolutionize the way mental health is treated throughout the United States. Phoenix, Arizona (PRWEB) September 28, 2016 The Cummings Institute is investigating the efficacy of virtual reality in the treatment of mental illness in partnership ...


Quick Search
Advertisement